Tentative identification of hemoglobin variants in the Bio-Rad VARIANT II Hb A1C method

被引:8
作者
Higgins, TN [1 ]
Ridley, B [1 ]
机构
[1] Dynacare Kasper Med Labs, Dept Chem, Edmonton, AB T5J 5E2, Canada
关键词
hemoglobin; Bio-Rad VARIANT II Hb A(1C); thalassemia;
D O I
10.1016/j.clinbiochem.2004.11.004
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Objective: To evaluate if peak characteristics, the retention time, and percentage of total hemoglobin of an unknown peak on the Bio-Rad VARIANT II Hb A(1c) method may be used to establish a tentative identification of hemoglobin variants. Method: The peak characteristics, retention time, and percentage of total hemoglobin obtained on abnormal peaks found oil the Bio-Rad VARIANT II Hb A(1c) method were tabulated and evaluated against the identification of the hemoglobin variant established by the Bio-Rad I thalassemia HPLC method and hemoglobin electrophoresis at both acid and alkaline pH. Results: Some hemoglobin variants show specific peak characteristics, retention times, and percentage of total hemoglobin on the BioRad VARIANT II Hb A(1c) method that allows for tentative identification of the hemoglobin variant. The retention times and percentage of hemoglobin variant for the common hemoglobin variants E, D, S, and C obtained on the Bio-Rad VARIANT II Hb A(1c) method are tabulated below. [GRAPHICS] Conclusion: Peak characteristics, retention times, and percentage of hemoglobin variant may be used to establish the presence of a hemoglobin variant and to provide a tentative identification of some hemoglobin variants on the Bio-Rad VARIANT II Hb A(1c) method. (C) 2004 The Canadian Society of Clinical Chemists. All rights reserved.
引用
收藏
页码:272 / 277
页数:6
相关论文
共 22 条
[1]  
*AM DIAB ASS, 2004, DIABETES CARE S1, V27, pS15
[2]  
Bry L, 2001, CLIN CHEM, V47, P153
[3]  
Capone LM, 2001, CLIN CHEM, V47, pA17
[4]  
Clarke GM, 2000, CLIN CHEM, V46, P1284
[5]  
*CLIN PRACT GUID E, 2003, CAN J DIABETES, V27, pS18
[6]  
De BK, 2004, CLIN CHEM, V50, pA110
[7]  
ELGHETANY MT, 2001, CLIN DIAGNOSIS MANAG, P542
[8]   Novel hemoglobin variant [β66(E10) Lys→Asn], with decreased oxygen affinity, causes falsely low hemoglobin A1c values by HPLC [J].
Friess, U ;
Beck, A ;
Kohne, E ;
Lehmann, R ;
Koch, S ;
Haring, HU ;
Schmuelling, RM ;
Schleicher, E .
CLINICAL CHEMISTRY, 2003, 49 (08) :1412-1415
[9]   Haemoglobinopathy diagnosed on HbA1c analysis [J].
Higgins, T .
ANNALS OF CLINICAL BIOCHEMISTRY, 2003, 40 :578-578
[10]   HPLC retention time as a diagnostic tool for hemoglobin variants and hemoglobinopathies: A study of 60,000 samples in a clinical diagnostic laboratory [J].
Joutovsky, A ;
Hadzi-Nesic, J ;
Nardi, MA .
CLINICAL CHEMISTRY, 2004, 50 (10) :1736-1747